The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world effectiveness and safety of trifluridine-tipiracil (FTD/TPI) and bevacizumab (BEV) in refractory metastatic colorectal cancer (mCRC): The BeTAS trial.
 
Nieves Martinez Lago
No Relationships to Disclose
 
Borja Gonzalez
No Relationships to Disclose
 
Elena Gallardo Martin
No Relationships to Disclose
 
Ana Fernandez Montes
Consulting or Advisory Role - Amgen; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; MSD
 
Antia Cousillas Castiñeira
No Relationships to Disclose
 
Begona Grana Suarez
No Relationships to Disclose
 
Alberto Carral Maseda
No Relationships to Disclose
 
Maria Luz Pellon Augusto
No Relationships to Disclose
 
Paula Gonzalez Villarroel
No Relationships to Disclose
 
Juan De La Camara Gomez
No Relationships to Disclose
 
Mercedes Salgado Fernández
No Relationships to Disclose
 
Margarita Reboredo Lopez
No Relationships to Disclose